Skip to main content

Advertisement

Erratum to: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

The original article was published in Breast Cancer Research 2006 8:R13

It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006.

In the Conclusions section the final sentence should read:

Questions such as the optimal duration of therapy and efficacy in stage I disease remain to be answered.

References

  1. 1.

    Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Research. 2006, 8: R13-10.1186/bcr1384.

Download references

Author information

Correspondence to Trevor Powles.

Additional information

The online version of the original article can be found at 10.1186/bcr1384

Rights and permissions

Reprints and Permissions

About this article